Attendees will hear about licensing and co-development opportunities from the NCI’s Dr. Mitchell Ho for a potential therapeutic treatment for COVID-19, “Single Domain Antibodies Targeting SARS-CoV2 for Treating Covid-19.” There [….]
NCI Tech Opportunity Webinar: Single Domain Antibodies Targeting SARS-CoV-2 for treating COVID-19
